Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Fuji
Deloitte
Cipla
QuintilesIMS
Julphar
McKesson
Daiichi Sankyo
Baxter

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021669

« Back to Dashboard

NDA 021669 describes CHLORHEXIDINE GLUCONATE, which is a drug marketed by Sage Prods, Apotex Inc, Hi Tech Pharma, Lyne, Teva, Wockhardt Bio Ag, Xttrium, Becton Dickinson, and Kendall Il, and is included in nine NDAs. It is available from twenty-seven suppliers. There are five patents protecting this drug. Additional details are available on the CHLORHEXIDINE GLUCONATE profile page.

The generic ingredient in CHLORHEXIDINE GLUCONATE is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 021669
Tradename:CHLORHEXIDINE GLUCONATE
Applicant:Sage Prods
Ingredient:chlorhexidine gluconate
Patents:5
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021669
Suppliers and Packaging for NDA: 021669
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669 NDA Sage Products, Inc. 53462-007 N 53462-007-27
CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669 NDA Sage Products, Inc. 53462-008 N 53462-008-28

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CLOTH;TOPICALStrength2%
Approval Date:Apr 25, 2005TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Feb 17, 2024Product Flag?Substance Flag?Delist Request?
Patented Use:DISINFECTION OF PATIENT SKIN PRIOR TO AN INVASIVE PROCEDURE
Patent:➤ Sign UpPatent Expiration:Apr 25, 2026Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:May 12, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:FOR THE PREPARATION OF SKIN PRIOR TO SURGERY; HELPS REDUCE BACTERIA THAT CAN POTENTIALLY CAUSE SKIN INFECTION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
UBS
Chinese Patent Office
McKesson
Teva
Accenture
Moodys
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot